Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

YM-087 in phase I for CHF

April 12, 1996

New angiotensin II antagonists from Kotobuki

April 12, 1996

Teijin reveals new agent for restenosis

April 5, 1996

New endothelin antagonists from RPR reported at 211th ACS

April 5, 1996

New agent for sudden cardiac death in phase I at Nortran

April 5, 1996

E. Merck claims Na+/H+-exchange inhibitors

April 5, 1996

New antiarrhythmics from Nisshin Flour Milling

April 5, 1996

Another antioxidant from Oxis: TX-153

April 5, 1996

BXT-51072 in line for clinical evaluation at Oxis

April 5, 1996

Novel vasoprotectants in AtheroGenics' pipeline

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...